-transparent.png){kind=logo}
The in vitro activity of cefoperazone (T-1551) against almost 9,000 recent clinical isolates at six institutions was tested and compared with that of cephalothin and gentamicin. The modal minimum inhibitory concentrations of cefoperazone were 16- and 4-fold less than those of cephalothin and gentamicin, respectively, against 5,503 strains of Enterobacteriaceae. Species normally resistant to cephalothin, such as indole-positive protease and enterobacters, were almost universally susceptible to cefoperazone. Cefoperazone demonstrated activity comparable to gentamicin against Pseudomonas aeruginosa and other pseudomonads.
Related Publications
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
December 1979,
Antimicrobial agents and chemotherapy,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
January 1980,
Clinical therapeutics,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
January 1980,
Clinical therapeutics,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
February 1967,
Munchener medizinische Wochenschrift (1950),
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
October 1972,
Antimicrobial agents and chemotherapy,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
March 1974,
La Clinica terapeutica,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
December 1979,
Schweizerische medizinische Wochenschrift,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
February 1964,
Deutsche medizinische Wochenschrift (1946),
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
January 1979,
The Journal of antibiotics,
R N Jones, and
P C Fuchs, and
A L Barry, and
T L Gavan, and
H M Sommers, and
E H Gerlach
February 1981,
Medizinische Klinik,
